medRxivGenetic & Genomic MedicinePreprint
Analysis of Blood Gene Expression Data Toward Early Detection of Alzheimer's Disease
Abstract
Alzheimers Disease (AD) is a progressive neurodegenerative disorder and the most commonly diagnosed cause of dementia, and it is the fifth leading cause of death among people aged 65 and older. During the years, the early diagnosis of AD patients has been a significant concern for researchers, in view of the fact that early diagnosis not only can lead to saving lives of the AD patients but also could bring a considerable amount of saving in health and long-term care expenditures for both people and the government. Mild cognitive impairment (MCI), defined as a transitional state between being healthy and having AD, is considered an established risk factor for AD. Hence, an accurate and reliable diagnosis of MCI and, consequently, discrimination between healthy people, MCI individuals, and AD patients can play a crucial role in the early diagnosis of AD. In recent years, analysis of blood gene expression data has been grabbed more attention than the conventional AD diagnosis method because it provides the opportunity to investigate the biochemical pathways, cellular functions, and regulatory mechanisms for finding the key genes associated with MCI and AD. Therefore, in this study, we employed blood gene expression data from Alzheimers Disease Neuroimaging Initiative (ADNI), two feature selection methods for determining the most prominent genes related to MCI and AD, and three classifiers for the most accurate discrimination between three groups of healthy, MCI and AD. The proposed method yielded the selection of top ten genes from more than 49,000 genes and the best overall classification result between healthy and AD patients with average values of the area under the curve (AUC) of 0.77 {+/-} 0.08. Furthermore, gene ontology (GO) analysis revealed that four genes were enriched with the GO terms of regulation of cell proliferation, negative regulation of cell population proliferation, signaling receptor binding, biological adhesion, and cytokine production.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
- Citations
- 6
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Working Towards a Blood-Derived Gene Expression Biomarker Specific for Alzheimer’s Disease
Hamel Patel, Raquel Iniesta, … Stephen Newhouse·Journal of Alzheimer s DiseasePeer-reviewed·Feb 11, 2020
- Identification of common molecular biomarker signatures in blood and brain of Alzheimers disease
Md Rezanur Rahman, Tania Islam, … Mohammad Ali Moni·bioRxiv·Jan 14, 2019
- Functional Genetic Biomarkers Of Alzheimer's Disease And Gene Expression From Peripheral Blood
Andrew Ni, Amish Sethi, Alzheimer’s Disease Neuroimaging Initiative·bioRxiv·Jan 15, 2021
- Tracking the progression of Alzheimer's disease with peripheral blood monocytes
Viktoriia Bavykina, Mariano Avino, … Benoît Laurent·bioRxiv·Feb 28, 2023
- Data-Driven Analysis of Age, Sex, and Tissue Effects on Gene Expression Variability in Alzheimer’s Disease
Lavida R. K. Brooks, George I. Mias·Frontiers in NeurosciencePeer-reviewed·Apr 24, 2019
- Identification of candidate biomarkers and signaling pathways associated with Alzheimer's disease using bioinformatics analysis of next generation sequencing data
Basavaraj Mallikarjunayya Vastrad, Chanabasayya Mallikarjunayya Vastrad·bioRxiv·Dec 3, 2024